FDA adds vision loss warning to Ozempic, Wegovy and other GLP-1 drugs

Newseze Wire·Wed, Nov 11, 6:53 PMWire: KGTV ABC 10 San Diego

The FDA will require GLP-1 drugs such as Ozempic and Wegovy to carry a warning about a rare but potentially serious vision loss risk.

Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by KGTV ABC 10 San Diego; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.

Newseze Analysis90 words · original commentary · full read loading…

The FDA will require GLP-1 drugs such as Ozempic and Wegovy to carry a warning about a rare but potentially serious vision loss risk. The story falls into Newseze's local desk and is being actively tracked by our editorial team. Calm framing, primary-source references, and respectful tone — every Newseze story is scored for drama and conspiracy before it reaches you. Worth knowing: Newseze refreshes its newsroom every hour and flags fast-moving local and breaking news as it develops. Watch this page for updates. Reporting: KGTV ABC 10 San Diego.

Ask Us · Any Story, Any AnswerBe the first to ask

Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.

No questions yet. Be the first.

Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.

FDA adds vision loss warning to Ozempic, Wegovy and other GLP-1 drugs

Related stories